Modulators of cystic fibrosis transmembrane conductance...

Details Modulators of cystic fibrosis transmembrane conductance... Modulators of cystic fibrosis transmembrane conductance...

2011-08-16

2011-08-16

Stockton, Laura L. (Department: 1626)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C514S371000

Reexamination Certificate

active

07999113

ABSTRACT:
The present invention relates to modulators of cystic fibrosis Transmembrane Conductance Regulator (“CFTR”), compositions thereof, and methods therewith. The present invention also relates to methods of treating CFTR mediated diseases using such modulators.

REFERENCES:
patent: 2005/0130970 (2005-06-01), Miller et al.
patent: 2007/0244159 (2007-10-01), Hadida-Ruah et al.
patent: 2008/0009524 (2008-01-01), Hadida-Ruah et al.
patent: 2008/0019915 (2008-01-01), Hadida-Ruah et al.
patent: 2008/0044355 (2008-02-01), Ruah et al.
patent: 2008/0113985 (2008-05-01), Ruah et al.
patent: 2008/0176899 (2008-07-01), Ruah et al.
patent: 2008/0286204 (2008-11-01), Hadida-Ruah et al.
patent: 2008/0306062 (2008-12-01), Hadida-Ruah et al.
patent: WO-2005/075435 (2005-08-01), None
International Search Report for corresponding PCT Application No. PCT/US2006/031457, Jun. 2, 2007.

Affiliated with

Also associated with

Rating

Modulators of cystic fibrosis transmembrane conductance... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Modulators of cystic fibrosis transmembrane conductance..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modulators of cystic fibrosis transmembrane conductance... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2770774